Second-degree Burn
📧 Sign up to get email alerts when something new happens for Second-degree Burn.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting [Phase 3]
Phase 3 clinical trial update for realSKIN as an alternative to autografting in burn wounds; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: MSCs for the Treatment of Burn Wounds [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating mesenchymal stem cells for treatment of burn wounds, including second- and third-degree burns.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns [Phase 4]
A Phase 4 comparative analysis study evaluating the cost-effectiveness of silver dressing in second-degree burns has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Pirfenidone and Its Role in Burn Wound Healing [Phase 2]
Phase 2 trial evaluating pirfenidone for burn wound healing has been completed.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Diagnostic of Infections Following Major Abdominal Surgery and Burn Injury
The clinical trial NCT01055587 has completed and evaluated diagnostic methods for detecting infections following major abdominal surgery and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-12-06Clinical Trial Update: Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating RPh201 for partial-thickness burns has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene® [NA]
This clinical trial compares Mepilex Ag and Silvadene for second-degree burns, evaluating cost-effectiveness as well as efficacy, safety, an…